Biblio
Found 312 results
Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif.. Bioorg Med Chem. 23(14):3948-56.
.
2015. Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration.. J Cereb Blood Flow Metab. 35(3):371-81.
.
2015. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.. Mol Neurobiol.
.
2015. Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism.. J Neurosci. 35(16):6307-17.
.
2015. Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities.. Neurotherapeutics. 12(1):66-80.
.
2015. Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury.. Brain Res. 1623:39-52.
.
2015. Temperature differentially facilitates spontaneous but not evoked glutamate release from cranial visceral primary afferents.. PLoS One. 10(5):e0127764.
.
2015. Therapeutic potential of peroxynitrite decomposition catalysts: a patent review.. Expert Opin Ther Pat. :1-24.
.
2015. Use of Animal Models in Understanding Cancer-induced Bone Pain.. Cancer Growth Metastasis. 8(Suppl 1):47-62.
.
2015. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.. EBioMedicine. 2(12):1888-904.
.
2015. Animal models for opioid addiction drug discovery.. Expert Opin Drug Discov. 9(11):1345-54.
.
2014. Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling.. Oncogene. 33(30):3970-9.
.
2014. Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.. Eur J Pharmacol. 736:124-30.
.
2014. Capsaicin-responsive corneal afferents do not contain TRPV1 at their central terminals in trigeminal nucleus caudalis in rats.. J Chem Neuroanat. 61-62:1-12.
.
2014. Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides.. Front Cell Neurosci. 8:471.
.
2014. Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury.. Front Cell Neurosci. 8:135.
.
2014. Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord.. J Am Chem Soc. 136(18):6608-16.
.
2014. Drug delivery to the ischemic brain.. Adv Pharmacol. 71:165-202.
.
2014. Environmental arsenic exposure and microbiota in induced sputum.. Int J Environ Res Public Health. 11(2):2299-313.
.
2014. Estrogen: a master regulator of bioenergetic systems in the brain and body.. Front Neuroendocrinol. 35(1):8-30.
.
2014. External QX-314 inhibits evoked cranial primary afferent synaptic transmission independent of TRPV1.. J Neurophysiol. 112(11):2697-706.
.
2014. Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.. Front Cell Neurosci. 8:203.
.
2014. The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth.. Front Cell Neurosci. 8:196.
.
2014. Hypermetabolic state in the 7-month-old triple transgenic mouse model of Alzheimer's disease and the effect of lipoic acid: a 13C-NMR study.. J Cereb Blood Flow Metab. 34(11):1749-60.
.
2014. Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery.. J Cereb Blood Flow Metab. 34(4):699-707.
.
2014.